3

FORM 3 SUBMISSION

Company: Amneal Pharmaceuticals, Inc.
Filed: March 16, 2020
Period of Report: March 12, 2020
Accession Number: 0000899243-20-008424

View Document ↗ View on SEC.gov ↗